(IH) Ihuman - Ratings and Ratios
Exchange: NYSE • Country: China • Currency: USD • Type: Common Stock • ISIN: US45175B1098
IH: Learning Apps, Educational Games, Interactive Books, Smart Devices
iHuman Inc. (NYSE:IH) is a leading provider of intellectual development products in China, catering to individual users, kindergartens, and distributors. The company offers a diverse portfolio of interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, and Aha World, among others. These apps are designed to foster critical thinking, independent reading, and creativity in children. In addition to its digital offerings, iHuman provides physical educational materials, such as books and smart devices, to enhance learning experiences. Founded in 1996 and headquartered in Beijing, the company has established itself as a key player in Chinas educational technology sector.
From a technical standpoint, IH has shown volatility with an Average True Range (ATR) of 0.09 over 20 days. The stock is currently trading at $2.11, above its 20-day SMA of $1.87 but in line with its 50-day and 200-day SMAs of $1.76. This indicates potential short-term upward momentum but a longer-term sideways trend.
Fundamentally, iHuman Inc. has a market cap of $97.65 million, with a P/E ratio of 7.19 and a forward P/E of 58.14, suggesting expectations of future earnings growth. The price-to-book ratio of 0.77 indicates undervaluation relative to its book value. The companys return on equity (RoE) of 11.38% reflects moderate profitability.
3-Month Forecast Based onAdditional Sources for IH Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IH Stock Overview
Market Cap in USD | 102m |
Sector | Consumer Defensive |
Industry | Education & Training Services |
GiC Sub-Industry | Restaurants |
IPO / Inception | 2020-10-09 |
IH Stock Ratings
Growth 5y | -61.7% |
Fundamental | 42.7% |
Dividend | 1.0% |
Rel. Strength | 6.04 |
Analysts | 5/5 |
Fair Price Momentum | 1.44 USD |
Fair Price DCF | 164.83 USD |
IH Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 100.0% |
IH Growth Ratios
Growth Correlation 3m | 84.9% |
Growth Correlation 12m | 17% |
Growth Correlation 5y | -76.5% |
CAGR 5y | -37.24% |
CAGR/Max DD 5y | -0.39 |
Sharpe Ratio 12m | -0.07 |
Alpha | 3.89 |
Beta | 0.367 |
Volatility | 108.56% |
Current Volume | 35.4k |
Average Volume 20d | 59.6k |
As of April 10, 2025, the stock is trading at USD 1.86 with a total of 35,356 shares traded.
Over the past week, the price has changed by -15.45%, over one month by -18.06%, over three months by +12.39% and over the past year by +4.49%.
Partly, yes. Based on ValueRay Fundamental Analyses, Ihuman (NYSE:IH) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.72 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IH as of April 2025 is 1.44. This means that IH is currently overvalued and has a potential downside of -22.58%.
Ihuman has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy IH.
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, IH Ihuman will be worth about 1.6 in April 2026. The stock is currently trading at 1.86. This means that the stock has a potential downside of -15.59%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 3.9 | 107.5% |
Analysts Target Price | 3.8 | 103.2% |
ValueRay Target Price | 1.6 | -15.6% |